Nanomedicine in the management of microbial infection – Overview and perspectives
Authors:
- 1 August 2014
- journal article
- Published by Elsevier in Nano Today
- Vol. 9 (4) , 478-498
Abstract
No abstract availableKeywords
Funding Information
- NIH (R00CA160350, U54-CA151884)
- David Koch – Prostate Cancer Foundation Program in Nanotherapeutics
- Movember-PCF Challenge Award
- PCF Young Investigator Award
- State Scholarship Fund of China
This publication has 180 references indexed in Scilit:
- Effects of dual antibacterial agents MDPB and nano-silver in primer on microcosm biofilm, cytotoxicity and dentine bond propertiesJournal of Dentistry, 2013
- Examination of bacterial resistance to exogenous nitric oxideNitric Oxide, 2012
- Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticlesBiomaterials, 2011
- Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunityVaccine, 2011
- Surface-Engineered Magnetic Nanoparticle Platforms for Cancer Imaging and TherapyAccounts of Chemical Research, 2011
- Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysisThe Lancet, 2011
- Eradication of drug resistant Staphylococcus aureus by liposomal oleic acidsBiomaterials, 2011
- Sustained release nitric oxide from long-lived circulating nanoparticlesFree Radical Biology and Medicine, 2010
- Emerging nanotechnology-based strategies for the identification of microbial pathogenesisAdvanced Drug Delivery Reviews, 2010
- Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticlesBiomaterials, 2009